Skip to content
Disclosery

Paradigm Biocapital Advisors LP: PCVX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Paradigm Biocapital Advisors LP on PCVX, newest first. How the timeline and the estimate are built.

Paradigm Biocapital Advisors LP held 2,127,852 PCVX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,127,852 shares
    Change vs previous 13F -2,665,168 shares

    2.32% of the 13F portfolio, value $123,692,037.

    13F-HR 0001855655-26-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,793,020 shares
    Change vs previous 13F +725,000 shares

    5.69% of the 13F portfolio, value $278,522,392.

    13F-HR 0001855655-26-000011 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 4,068,020 shares
    Change vs previous 13F +283,265 shares

    5.03% of the 13F portfolio, value $187,698,443.

    13F-HR 0001855655-26-000003 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,784,755 shares
    Change vs previous 13F +411,918 shares

    4.03% of the 13F portfolio, value $136,326,875.

    13F-HR 0001855655-25-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,372,837 shares
    Change vs previous 13F +1,676,356 shares

    4.68% of the 13F portfolio, value $109,650,931.

    13F-HR 0001855655-25-000010 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,696,481 shares
    Change vs previous 13F +273,694 shares

    2.95% of the 13F portfolio, value $64,059,123.

    13F-HR 0001855655-25-000007 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,422,787 shares
    Change vs previous 13F +795,055 shares

    4.05% of the 13F portfolio, value $116,469,344.

    13F-HR 0001855655-25-000004 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 627,732 shares
    Change vs previous 13F not available

    2.51% of the 13F portfolio, value $71,730,936.

    13F-HR 0001855655-24-000014 filed by Paradigm Biocapital Advisors LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).